MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore Li-Fraumeni Syndrome, TP53 mutations, and genetic testing. Learn how early detection aids in cancer risk management and family planning for affected individuals.
Explore the role of genetic testing in diagnosing Lichen Planopilaris. Discover personalized treatments, genetic predispositions, and future research directions.
Explore the impact of genetic testing on lip and oral cavity carcinoma. Discover risk factors, preventive strategies, and personalized treatment plans for better outcomes.
Explore Loeys-Dietz Syndrome, a rare genetic disorder affecting connective tissue. Learn how genetic testing aids in early diagnosis and personalized management.
Explore how genetic testing unveils insights into lymphatic malformations, identifying mutations like PIK3CA, and paving the way for personalized treatment strategies.
Explore how genetic testing reveals the genetic roots of lymphedema, aids in diagnosis, guides treatment, and offers insights for future research advancements.
Mantle cell lymphoma, a rare non-Hodgkin lymphoma, benefits from genetic testing for early detection, personalized treatments, and monitoring progression.
Unlock personalized treatment plans for MODY with genetic testing. Understand the genetic factors impacting diagnosis and management for improved patient outcomes.